Niki BioSolutions, Inc. Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest
Niki BioSolutions, Inc. (NIKI) had Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest of $13.74 million as of 2025-12-31, per its S-4/A filed 2026-05-11.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest · last filed 2026-05-11
- 2025-12-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $13.74M.
- 2025-09-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $13.16M.
- 2025-06-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $13.77M.
- 2024-12-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $11.78M.
| Period end | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest |
|---|---|
| 2025-12-31 | $13.74M S-4/A · filed 2026-05-11 |
| 2025-09-30 | $13.16M 6-K · filed 2026-01-22 |
| 2025-06-30 | $13.77M 6-K · filed 2025-10-08 |
| 2024-12-31 | $11.78M S-4/A · filed 2026-05-11 |
| 2024-09-30 | $12.51M 6-K · filed 2026-01-22 |
| 2024-06-30 | $13.18M 6-K · filed 2025-10-08 |
| 2023-12-31 | $15.38M S-4/A · filed 2026-05-11 |
| 2023-06-30 | $12.78M 6-K · filed 2024-12-20 |
| 2022-12-31 | $7.83M S-4/A · filed 2026-05-11 |
| 2022-06-30 | $15.65M 6-K · filed 2023-12-22 |
| 2021-12-31 | $17.51M 6-K · filed 2025-10-08 |
| 2021-06-30 | $26.47M 6-K · filed 2022-09-30 |
| 2020-12-31 | $38.15M 20-F · filed 2024-04-30 |
| 2020-06-30 | $17.52M 6-K · filed 2021-09-15 |
| 2019-12-31 | $14.85M 20-F · filed 2023-04-28 |
| 2019-06-30 | $24.02M 6-K · filed 2020-09-02 |
| 2018-12-31 | $32.75M 20-F/A · filed 2023-01-17 |
| 2017-12-31 | $30.23M 20-F · filed 2021-04-19 |
| 2017-02-28 | $24.49M 20-F · filed 2020-04-29 |